Dr. Gurpreet S. Baweja

Dr. Gurpreet (Gary) Baweja has been caring for patients’ hearts as a board-certified interventional cardiologist since 1998 and has been a trusted resource in the Fort Worth community since 2007. He has additional training and board certification in cardiovascular diseases, nuclear cardiology, and echocardiography. Dr. Baweja received advanced cardiac imaging training, including Level III certification in echocardiography (essential training required to be a clinical lab director) and cardiac CT. He is also board-eligible in vascular medicine to perform endovascular procedures.Dr. Baweja currently holds several leadership positions within Texas Health Harris Methodist Hospital Fort Worth, including chairman of Cardiovascular Services, director of Invasive Cardiology and the Cardiac Catheterization Lab, and cardiology sub-specialty director for the hospital’s Internal Medicine Residency Program. He is an active participant and lead investigator in trials involving cardiovascular disease, medications, and devices. His clinical expertise includes cardiac catheterization, complex percutaneous coronary and peripheral endovascular interventions, carotid stenting, left atrial closures using the Watchman procedure, and PFO/ASD closures. Dr. Baweja earned his medical degree from King George’s Medical College in India. He completed his internal medicine residency at SUNY Downstate Health Sciences University in Brooklyn, N.Y., and his fellowship training in cardiovascular diseases and interventional cardiology at the University of Arizona Sarver Heart Center in Tucson. Dr. Baweja is a Fellow of the American Society of Echocardiography, American College of Cardiology, and Society for Cardiovascular Angiography and Interventions. Away from the office, he enjoys spending time with his family, exploring new destinations as a globe-trotting traveler, and perfecting his swing as an avid golfer.

Dr. Baweja is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Heart Attack, Arterial Embolism, Carotid Artery Disease, Arterial Insufficiency, and Atherectomy.

He is actively involved in clinical research, participating in 1 clinical trial.